Roundtable: Limiting the Immunogenicity & Off-Target Effects of Editing Platforms to Enhance Therapeutic Safety & Efficacy
Time: 4:30 pm
day: Day Two
Details:
- Discuss the immunogenicity risks of bacteria-derived genome editing proteins alongside the delivery capsid
- Comprehend design strategies for building a genome editing platform to reduce immunogenicity and off-target effects
- Reinstate how addressing immunogenicity is key to maintaining a platform that is safe and efficacious
